🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

⚡️ In Nature Reviews Urology - Circulating tumour DNA and circulating tumour cells in bladder cancer — from discovery to clinical implementation #BladderCancer nature.com/articles/s4158…

JUST IN: U.S. FDA approves mitomycin intravesical solution for recurrent low-grade intermediate-risk non-muscle invasive bladder cancer! Approval based on ENVISION NCT05243550 trial ! Dana-Farber Lank Center for Genitourinary Oncology Amer. Urol. Assn.

#ASCO25 was special—my first as GI Division Chief Fox Chase Cancer Center. Inspiring GI science, QoL in focus, and energizing meetups with mentors & friends. Proud to see our team shine—abstracts, faculty role and session chairs, and trainees presenting! ASCO

The best #ValentinesDay gift ever (it’s today in 🇧🇷) from Cristiane D Bergerot 🥰 An ExIO study mug featuring our paper at Supportive Care in Cancer: Springer Journal!! #DiaDosNamorados” link.springer.com/article/10.100…

Incredibly well deserved, congratulations Toni Choueiri, MD!

Congratulations Toni Choueiri, MD! So well-deserved and a true testament to your huge impact on our field 👏👏

A non-androgen targeted approach might be an alternative in patients with metastatic castration resistant prostate cancer who have progressive disease with ARPI❓ CONTACT-02 Phase ⤵️ ✅Cabozantinib + atezolizumab significantly improved progression-free survival vs ARPI switch

Just in Clinical Cancer Research 👉Congrats Chadi Hage Chehade Umang Swami & GU Cancer Research Program @HuntsmanCancer team👉Poor outcomes w/ SOC Rx in mHSPC #prostatecancer w/HRRm in 637 real-world US pts👇 Flatiron Health Foundation Medicine Ryon Graf, PhD 👉 need to add PARPi 👉free link: bit.ly/3TsOw9i OncoAlert UroToday.com

Excited to see our work published in Clinical Cancer Research ! Real-world pts w/ mHSPC #prostatecancer w/ HRRalt had worse survival than those w/ non-altered HRR 👉bit.ly/3TsOw9i👇 Grateful for terrific support from team Ryon Graf, PhD Umang Swami Neeraj Agarwal, MD, FASCO UroToday.com OncoAlert

Thank you HemOnc Today for highlighting our research! IMG fellows demonstrated higher research productivity than AMG counterparts in terms of higher # of manuscripts, abstracts, first author articles. IMG Oncologists Toni Choueiri, MD Ziad Bakouny, MD, MSc Nazli Dizman Fatemeh Ardeshir, MD

Our Dana-Farber Lank Center for Genitourinary Oncology and Signoretti Lab are looking for a junior pathologist/resident (at least 1 year of residency training) to join our group and lead one of our translational efforts in kidney cancer. Training in general pathology is ok as long as it is 6-12 months. Please

🏆 The Yvonne Awards 2025 by OncoDaily Dario Trapani | Dr. Catharine Young | Bishal Gyawali, MD, PhD, FASCO | Darya Kizub, MD 🇺🇦 | Stella Kyriakides | Daniel Heng | Jasmine Kamboj, MD, FASCO | Marta Salek | Paolo Tarantino The Yvonne Awards 2025, presented by OncoDaily, took place on May 30th during ASCO 2025 in Chicago, set

Congrats to the ⁦National Cancer Institute⁩ Team on this landmark paper in HLRCC! It sets the SOC in this rare kidney cancer variant. ⁦NEJM⁩ ⁦NCI Surgical Oncology⁩ ⁦NCI CCR GU Malignancies⁩ nejm.org/doi/full/10.10…

📢 Big win for a rare kidney cancer subtype! In HLRCC-associated papillary RCC, bevacizumab + erlotinib delivered a 72% response rate and median PFS of 21.1 months. 🧬 Germline FH-mutated pRCC finally gets a targeted shot. #Oncology #RCC #HLRCC #KidneyCancer #PrecisionMedicine

Proud to be part of this pivotal trial and to have learned so much from Dr. Srinivasan and our patients. ⁦National Cancer Institute⁩⁩ ⁦The James⁩ ⁦Ohio State Wexner Medical Center Urology Dept.⁩ ⁦Kimryn Rathmell⁩ ⁦Kidney Cancer⁩ ⁦KidneyCAN⁩ ⁦IKCC Kidney Cancer⁩ ⁦⁦Kidney Cancer Canada⁩

Congratulations to Emre Yekedüz for joining the editorial board of The Oncologist The Oncologist A brilliant mind now helping shape the future of cancer care. Ankara Üniversitesi

Our GI Medical Oncology team at MD Anderson Cancer Center is hiring! We are committed to build up medical oncologists excelling in patient care & who will lead research efforts to #endcancer for #crcsm pts - & we are a very fun team to work with 😉 bit.ly/44cVHYs

Honored and grateful to receive the SOHO YIT Scholarship for second year in a row! Houston, here I come again excited to reconnect, learn, and grow alongside some of the brightest minds in hematologic oncology at SOHO 2025 Society of Hematologic Oncology (SOHO) OncoDaily IMG Oncologists Women in Oncology

1/5 This comes up in #kidneycancer clinic every few months. And on patient groups just as often. 📊 The ASSURE nomogram shows cumulative disease-free survival (DFS) from time 0 after surgery. Great info… until someone hits the 2-year mark and panics at that 48.8% 3-year number.